Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10071)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 14, 2018 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Facciorusso A. Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art. World J Gastroenterol 2018; 24(2): 161-169 [PMID: 29375202 DOI: 10.3748/wjg.v24.i2.161] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v24/i2/161.htm |
| Number | Citing Articles |
| 1 |
Marwa Ahmed Sakr, Khaled Abdel Hamid Mohamed, Ahmed Mohamed Hussein, Mohamed Hassan Fouad, Ahmed Samir Allam, Eslam Safwat. Diagnostic and prognostic value of serum soluble CD163 in cirrhotic patients with hepatitis C virus-related hepatocellular carcinoma before and after locoregional therapy. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00090-y
|
| 2 |
Chuangen Guo, Cheng Wang, Jingfeng Zhang, Xiao Chen. <p>Treatment for Liver Tumor Using Combined Transarterial Embolization and Interaarterial Transfecting HIF-1α shRNA in a Rabbit VX2 Model</p>. OncoTargets and Therapy 2020; : 8511 doi: 10.2147/OTT.S262434
|
| 3 |
Murtuza Razi, Gu Jianping, He Xu, Mohammed Jameeluddin Ahmed. Conventional versus drug-eluting bead transarterial chemoembolization: A better option for treatment of unresectable hepatocellular carcinoma. Journal of Interventional Medicine 2021; 4(1): 11 doi: 10.1016/j.jimed.2020.10.006
|
| 4 |
Yan Zhang, Mei-Wu Zhang, Xiao-Xiang Fan, Da-Feng Mao, Quan-Hua Ding, Lu-Hui Zhuang, Shu-Yi Lv. Drug-eluting beads transarterial chemoembolization sequentially combined with radiofrequency ablation in the treatment of untreated and recurrent hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2020; 12(8): 355-368 doi: 10.4240/wjgs.v12.i8.355
|
| 5 |
Wenhua Wang, Lingchen Wang, Xinsheng Xie, Yehong Yan, Yue Li, Quqin Lu. A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-020-07692-6
|
| 6 |
Corinne E. Wessner, Colette M. Shaw, Maria Stanczak, Flemming Forsberg, Andrej Lyshchik, Allison Tan, John R. Eisenbrey. Contrast-enhanced Ultrasound Identifies Patent Feeding Vessels in Transarterial Chemoembolization Patients With Residual Tumor Vascularity. Ultrasound Quarterly 2020; 36(3): 218 doi: 10.1097/RUQ.0000000000000513
|
| 7 |
Sirish A. Kishore, Raazi Bajwa, David C. Madoff. Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 Update. Cancers 2020; 12(4): 791 doi: 10.3390/cancers12040791
|
| 8 |
Seóna M. Rossi, Benedict K. Ryan, Helena M. Kelly. Evaluation of the activity of a chemo-ablative, thermoresponsive hydrogel in a murine xenograft model of lung cancer. British Journal of Cancer 2020; 123(3): 369 doi: 10.1038/s41416-020-0904-9
|
| 9 |
Victoria Susanne Antonia Habbel, Martin Zeile, Gregor Alexander Stavrou, Frank Wacker, Roland Brüning, Karl-Jürgen Oldhafer, Thomas Rodt. Correlation between SACE (Subjective Angiographic Chemoembolization Endpoint) score and tumor response and its impact on survival after DEB-TACE in patients with hepatocellular carcinoma. Abdominal Radiology 2019; 44(10): 3463 doi: 10.1007/s00261-019-02128-7
|
| 10 |
Amira Isaac, Sherif Mounir Mohamed, Osama Ashraf Ahmed, Ahmed Gamal Mohamed Hassan, Hany Samir Rasmy. Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment. The Egyptian Journal of Internal Medicine 2021; 33(1) doi: 10.1186/s43162-021-00078-5
|
| 11 |
Tarik Silk, Mikhail Silk, Jennifer Wu. Up to seven criteria in selection of systemic therapy for hepatocellular carcinoma. World Journal of Gastroenterology 2022; 28(23): 2561-2568 doi: 10.3748/wjg.v28.i23.2561
|
| 12 |
Abheek Ghosh, Vikash Gupta, Abdullah Al Khalifah, Nabeel Mohsin Akhter. Transradial versus transfemoral arterial access in DEB-TACE for hepatocellular carcinoma. Journal of Clinical Imaging Science 2022; 12: 38 doi: 10.25259/JCIS_47_2022
|
| 13 |
Lisa S. Parks, Patricia Little. Cirrhosis, Hepatocellular Carcinoma, and Locoregional Therapies. Journal of Radiology Nursing 2022; 41(2): 129 doi: 10.1016/j.jradnu.2022.01.005
|
| 14 |
Antonio Facciorusso, Irene Bargellini, Marina Cela, Ivan Cincione, Rodolfo Sacco. Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis. Cancers 2020; 12(4): 897 doi: 10.3390/cancers12040897
|
| 15 |
Chuzhi Shang, Mi Ke, Lin Liu, Cong Wang, Yufang Liu, Xin Zheng. RETRACTED: Exosomes From Cancer-Associated Mesenchymal Stem Cells Transmit TMBIM6 to Promote the Malignant Behavior of Hepatocellular Carcinoma via Activating PI3K/AKT Pathway. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.868726
|
| 16 |
Na Zhang, Xiao-Feng He, Xiang-Ke Niu. Mapping research trends of transarterial chemoembolization for hepatocellular carcinoma from 2012 to 2021: A bibliometric analysis. World Journal of Methodology 2023; 13(4): 345-358 doi: 10.5662/wjm.v13.i4.345
Abstract(336) |
Core Tip(245) |
Full Article(HTML)(826)
|
Full Article with Cover (PDF)-36372K(56)
|
Full Article (Word)-8711K(37)
|
Audio-5356K(2)
|
Peer-Review Report-256K(29)
|
Answering Reviewers-356K(31)
|
Supplementary Material-341K(36)
|
Full Article (PDF)-36160K(66)
|
Full Article (XML)-129K(27)
|
Times Cited (0)
|
Total Visits (2815)
|
Open
|
| 17 |
Baojian Li, Liaqat Ali. Prophylactic Use of Antibiotics for Postsurgical Infection in c-TACE and DEB-TACE High-Risk Patients: A Case-Control Study. Journal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/6203817
|
| 18 |
Masatoshi Kudo, Richard S. Finn, Manabu Morimoto, Kun-Ming Rau, Masafumi Ikeda, Chia-Jui Yen, Peter R. Galle, Josep M. Llovet, Bruno Daniele, Ho Yeong Lim, David W. McIlwain, Reigetsu Yoshikawa, Kenichi Nakamura, Kun Liang, Chunxiao Wang, Paolo Abada, Ryan C. Widau, Andrew X. Zhu. Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2). Liver Cancer 2021; 10(5): 451 doi: 10.1159/000516605
|
| 19 |
Κ. Malagari, Th. Kiakidis, Hip. Moschouris, M. Deutsch, S. Tanteles, Eir. Pantou, I. Panagiotou, J. Koskinas, G. K. Glantzounis, A. Alexopoulou, D. Filippiadis, E. Brountzos, N. Kelekis. Safety, Efficacy and Distribution of Doxorubicin Loaded Radiopaque Beads in Chemoembolization in Intermediate Stage Hepatocellular Carcinoma (HCC) with Correlation with Local Response. CardioVascular and Interventional Radiology 2023; 46(3): 337 doi: 10.1007/s00270-022-03346-1
|
| 20 |
Amar Karalli, Johan Teiler, Mojgan Haji, Elin Seth, Torkel B. Brismar, Staffan Wahlin, Rimma Axelsson, Per Stål. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting. Scandinavian Journal of Gastroenterology 2019; 54(7): 905 doi: 10.1080/00365521.2019.1632925
|
| 21 |
Cristina Mosconi, Alberta Cappelli, Cinzia Pettinato, Maria Adriana Cocozza, Giulio Vara, Eleonora Terzi, Maria Cristina Morelli, Elisa Lodi Rizzini, Matteo Renzulli, Francesco Modestino, Matteo Serenari, Rachele Bonfiglioli, Letizia Calderoni, Elena Tabacchi, Matteo Cescon, Alessio Giuseppe Morganti, Franco Trevisani, Fabio Piscaglia, Stefano Fanti, Lidia Strigari, Alessandro Cucchetti, Rita Golfieri. Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added Value. Journal of Clinical Medicine 2022; 11(24): 7469 doi: 10.3390/jcm11247469
|
| 22 |
Arnold Man Nok Chui, Thomas Chung Cheung Yau, Tan To Cheung. An overview in management of hepatocellular carcinoma in Hong Kong using the Hong Kong Liver Cancer (HKLC) staging system. Global Health & Medicine 2020; 2(5): 312 doi: 10.35772/ghm.2020.01062
|
| 23 |
Degang Kong, Tao Jiang, Jian Liu, Xinyi Jiang, Bei Liu, Cheng Lou, Baobing Zhao, Steven L. Carroll, Gong Feng. Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal. Drug Delivery 2020; 27(1): 1729 doi: 10.1080/10717544.2020.1856219
|
| 24 |
Meijuan Wang, Yanan Gao, Xiaoya Liu, Zhihua Li, Jingyu Xiao, Xu Gao, Matthew I. Gibson, Qiongyu Guo. Cirrhotic hepatocellular carcinoma-based decellularized liver cancer model for local chemoembolization evaluation. Acta Biomaterialia 2024; 176: 144 doi: 10.1016/j.actbio.2024.01.020
|
| 25 |
Li-Fang Bian, Xue-Hong Zhao, Bei-Lei Gao, Sheng Zhang, Guo-Mei Ge, Dong-Di Zhan, Ting-Ting Ye, Yan Zheng. Predictive model for acute abdominal pain after transarterial chemoembolization for liver cancer. World Journal of Gastroenterology 2020; 26(30): 4442-4452 doi: 10.3748/wjg.v26.i30.4442
|
| 26 |
Xu Gao, Zijian Chen, Zhengchang Chen, Xiaoya Liu, Yucheng Luo, Jingyu Xiao, Yanan Gao, Yutao Ma, Chuang Liu, Hwa Liang Leo, Hanry Yu, Qiongyu Guo. Visualization and Evaluation of Chemoembolization on a 3D Decellularized Organ Scaffold. ACS Biomaterials Science & Engineering 2021; 7(12): 5642 doi: 10.1021/acsbiomaterials.1c01005
|
| 27 |
Xiaoya Liu, Xueying Wang, Yucheng Luo, Meijuan Wang, Zijian Chen, Xiaoyu Han, Sijia Zhou, Jiahao Wang, Jian Kong, Hanry Yu, Xiaobo Wang, Xiaoying Tang, Qiongyu Guo. A 3D Tumor‐Mimicking In Vitro Drug Release Model of Locoregional Chemoembolization Using Deep Learning‐Based Quantitative Analyses. Advanced Science 2023; 10(11) doi: 10.1002/advs.202206195
|
| 28 |
Stefan O. Schoenberg, Ulrike I. Attenberger, Stephen B. Solomon, Ralph Weissleder. Developing a Roadmap for Interventional Oncology. The Oncologist 2018; 23(10): 1162 doi: 10.1634/theoncologist.2017-0654
|
| 29 |
Aigerim Karina, Abderazak Benzina, Samal Tazhibayeva, Haiyan Fan, Levinus H. Koole. Polymer microparticles with a cavity designed for transarterial chemo‐embolization with crystalline drug formulations. Journal of Biomedical Materials Research Part B: Applied Biomaterials 2021; 109(3): 401 doi: 10.1002/jbm.b.34708
|
| 30 |
Hai-Dong Zhu, Xiao Li, Jun-Hui Sun, Xu Zhu, Zhao-Yu Liu, Hai-Liang Li, Jian Lu, Zhi-Ping Yan, Guo-Liang Shao, Xiao-Feng He, Min Chao, Li-Gong Lu, Bin-Yan Zhong, Rui Li, Qi Zhang, Gao-Jun Teng. Transarterial Chemoembolization with Epirubicin-Loaded Microspheres for Hepatocellular Carcinoma: A Prospective, Single-Arm, Multicenter, Phase 2 Study (STOPPER Trial). CardioVascular and Interventional Radiology 2024; 47(3): 325 doi: 10.1007/s00270-024-03666-4
|
| 31 |
Felix Peisen, Michael Maurer, Ulrich Grosse, Konstantin Nikolaou, Roland Syha, Dominik Ketelsen, Christoph Artzner, Michael Bitzer, Marius Horger, Gerd Grözinger. Predictive performance of the mHAP-II score in a real-life western cohort with hepatocellular carcinoma following trans-arterial chemoembolisation with drug-eluting beads (DEB-TACE). European Radiology 2020; 30(7): 3782 doi: 10.1007/s00330-020-06734-8
|
| 32 |
Lin Li, Wenzhuo Zhao, Mengmeng Wang, Jie Hu, Enxin Wang, Yan Zhao, Lei Liu. Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0849-0
|
| 33 |
Tianshi Lyu, Hang Yao, Jian Wang, Li Song, Xiaoqiang Tong, Yinghua Zou. Treatment response, survival and safety profile of transarterial chemoembolization using different sizes of drug-eluting beads in hepatocellular carcinoma patients with portal vein tumor thrombus. Clinics and Research in Hepatology and Gastroenterology 2022; 46(4): 101819 doi: 10.1016/j.clinre.2021.101819
|
| 34 |
Tommaso Cascella, Enrico Matteo Garanzini, Rodolfo Lanocita, Carlo Morosi, Federica Riva, Giorgio Greco, Carlo Sposito, Vincenzo Mazzaferro, Alfonso Marchianò, Carlo Spreafico. Long Term Survival Analysis in a Cohort of 125 Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using Small Drug Eluting Beads. CardioVascular and Interventional Radiology 2022; 45(1): 54 doi: 10.1007/s00270-021-02991-2
|
| 35 |
Jun Deng, Feng Wen. Transarterial Chemoembolization Combined With Tyrosine Kinase Inhibitors for Intermediate‐Stage Hepatocellular Carcinoma, What Else Can We Do?. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.824799
|
| 36 |
Lei Cao, Yu-Qin Zhu, Zhi-Xian Wu, Gao-Xiong Wang, Hong-Wei Cheng. Engineering nanotheranostic strategies for liver cancer. World Journal of Gastrointestinal Oncology 2021; 13(10): 1213-1228 doi: 10.4251/wjgo.v13.i10.1213
|
| 37 |
Jingyu Xiao, Dishuang Yang, Xiaofeng Fang, Xiaoya Liu, Xuezhe Liu, Le Ma, Ziyan Wang, Changfeng Wu, Qiongyu Guo. Near Infrared-Absorbing Nanoparticle-Mediated Endovascular Photothermal Precision Embolization of Tumor Feeding Vessels for Starvation Treatment. ACS Biomaterials Science & Engineering 2023; 9(6): 3660 doi: 10.1021/acsbiomaterials.3c00287
|
| 38 |
Anne Hulin, Jeanick Stocco, Mohamed Bouattour. Clinical Pharmacokinetics and Pharmacodynamics of Transarterial Chemoembolization and Targeted Therapies in Hepatocellular Carcinoma. Clinical Pharmacokinetics 2019; 58(8): 983 doi: 10.1007/s40262-019-00740-w
|
| 39 |
Deniz Tümen, Philipp Heumann, Karsten Gülow, Cagla-Nur Demirci, Lidia-Sabina Cosma, Martina Müller, Arne Kandulski. Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma. Biomedicines 2022; 10(12): 3202 doi: 10.3390/biomedicines10123202
|
| 40 |
Sitong Wu, Kevin Fan, Qi Yang, Zhao Chen, Yi Hou, Yinghua Zou, Weibo Cai, Lei Kang. Smart nanoparticles and microbeads for interventional embolization therapy of liver cancer: state of the art. Journal of Nanobiotechnology 2023; 21(1) doi: 10.1186/s12951-023-01804-7
|
| 41 |
Begül Yağcı‐Küpeli, Tuğsan Ballı. Hepatoblastoma treated successfully with drug‐eluting bead transarterial chemoembolization: Outcome of seven‐year follow‐up. Pediatric Blood & Cancer 2021; 68(8) doi: 10.1002/pbc.29063
|
| 42 |
Jakub Fichtl, Vladislav Třeška, Tomáš Skalický, Václav Liška, Josef Vodička, Petr Duras, Jakub Šebek, Kristýna Procházková. Transarterial chemoembolization as a palliative treatment for primary and secondary liver cancers: the 2013-2017 cohort of the Pilsen University Hospital. Onkologie 2021; 14(6): 287 doi: 10.36290/xon.2020.095
|
| 43 |
Gaofeng Sun, Tao Wang, Xiao Li, Danni Li, Ye Peng, Xiaoke Wang, Guorong Jia, Weiwei Su, Chao Cheng, Jian Yang, Changjing Zuo. Sub‐Micrometer Au@PDA‐125I Particles as Theranostic Embolism Beads for Radiosensitization and SPECT/CT Monitoring. Advanced Healthcare Materials 2018; 7(16) doi: 10.1002/adhm.201800375
|
| 44 |
K. Malagari, H. Moschouris, Th. Kiakidis, S. Harward, A. Kelekis, S. Vrakas, D. Koundouras, D. Filipiadis, G. Glantzounis, E. Emmanouil, A. Chatziioannou, V. Vergadis, I. Elefsiniotis, J. Koskinas, S. Dourakis, N. Kelekis. Five-Years Outcome Analysis of 142 Consecutive Hepatocellular Carcinoma Patients Treated with Doxorubicin Eluting Microspheres 30–60 μm: Results from a Single-Centre Prospective Phase II Trial. CardioVascular and Interventional Radiology 2019; 42(11): 1551 doi: 10.1007/s00270-019-02260-3
|
| 45 |
Liang Cai, Honglu Li, Jiang Guo, Wenpeng Zhao, Youjia Duan, Xiaopu Hou, Long Cheng, Hongliu Du, Xihong Shao, Zhenying Diao, Changqing Li. Drug-eluting bead transarterial chemoembolization is an effective downstaging option for subsequent radical treatments in patients with hepatocellular carcinoma: A cohort study. Clinics and Research in Hepatology and Gastroenterology 2021; 45(4): 101535 doi: 10.1016/j.clinre.2020.09.002
|
| 46 |
Cristiana Bergamini, Stefano Cavalieri, Tommaso Cascella, Rodolfo Lanocita, Salvatore Alfieri, Carlo Resteghini, Francesca Platini, Ester Orlandi, Laura Deborah Locati, Alfonso Marchianò, Lisa Licitra. Local therapies for liver metastases of rare head and neck cancers: A monoinstitutional case series. Tumori Journal 2020; : 030089162095284 doi: 10.1177/0300891620952844
|
| 47 |
Takuji Torimura, Hideki Iwamoto. Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects. Clinical and Molecular Hepatology 2021; 27(2): 236 doi: 10.3350/cmh.2020.0204
|
| 48 |
Chia-Ying Lin, Yi-Sheng Liu, Kuang-Tse Pan, Chia-Bang Chen, Chein-Fu Hung, Chen-Te Chou. The short-term safety and efficacy of TANDEM microspheres of various sizes and doxorubicin loading concentrations for hepatocellular carcinoma treatment. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91021-9
|
| 49 |
Kensuke Yamamura, Toru Beppu, Nobutaka Sato, Eri Oda, Koichi Kinoshita, Hideaki Yuki, Toshihiko Motohara, Hideaki Miyamoto, Tsutomu Oda, Shinichi Akahoshi. Huge hepatocellular carcinoma with extrahepatic collateral arteries successfully treated by multidisciplinary treatment including laparoscopic devascularization: a case report. Clinical Journal of Gastroenterology 2021; 14(1): 251 doi: 10.1007/s12328-020-01286-2
|
| 50 |
Xiaojun Wang, Huiyun Zhang, Liangfen Zhou, Hui Ou, Hengyu Liu. Efficacy and Safety of 8 spheres Plus Cisplatin Versus Vinorelbine Plus Cisplatin in Locally Advanced Non-small Cell Lung Cancer. Cancer Biotherapy and Radiopharmaceuticals 2023; 38(5): 313 doi: 10.1089/cbr.2020.4301
|
| 51 |
Lorena Baboci, Sara Capolla, Federica Di Cintio, Federico Colombo, Prisca Mauro, Michele Dal Bo, Monica Argenziano, Roberta Cavalli, Giuseppe Toffoli, Paolo Macor. The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target. Journal of Oncology 2020; 2020: 1 doi: 10.1155/2020/4638192
|
| 52 |
Tianshi Lyu, Jian Wang, Xiaoqiang Tong, Tianai Mi, Chao An, Yinghua Zou. Efficacy and safety of CalliSpheres® Microsphere transcatheter-arterial chemoembolization versus conventional TACE in treating renal angiomyolipoma patients. Journal of Cancer Research and Therapeutics 2023; 19(4): 933 doi: 10.4103/jcrt.jcrt_2135_22
|
| 53 |
Zhongxing Shi, Dongqing Wang, Tanrong Kang, Ru Yi, Liming Cui, Huijie Jiang. Comparison of CalliSpheres® microspheres drug-eluting beads and conventional transarterial chemoembolization in hepatocellular carcinoma patients: a randomized controlled trial. Radiology and Oncology 2023; 57(1): 70 doi: 10.2478/raon-2023-0001
|
| 54 |
Monica Mossenta, Davide Busato, Michele Dal Bo, Paolo Macor, Giuseppe Toffoli. Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies. International Journal of Molecular Sciences 2022; 23(17): 10038 doi: 10.3390/ijms231710038
|
| 55 |
Kai-Cai Liu, Wei-Fu lv, Dong Lu, Chang-Long Hou, Jun Xie, Yu-He Lu, Qi-Sheng Cao, Yu-Lin Tan, Ying-Zhan Zhang, Jie Liu. Initial Experience of Drug-Eluting Bead-Transcatheter Arterial Chemoembolization After Lipiodol-Based Transcatheter Arterial Chemoembolization Failure for Patients with Advanced Hepatocellular Carcinoma. Cancer Management and Research 2021; : 7973 doi: 10.2147/CMAR.S332571
|
| 56 |
Andrea Chierici, Andrew Ofosu, Ivan Cincione, Rodolfo Sacco, Christian Cotsoglou, Antonio Facciorusso. Transarterial chemoembolization as adjuvant treatment after surgery: The cure of huge hepatocellular carcinoma?. Hepatobiliary & Pancreatic Diseases International 2021; 20(3): 205 doi: 10.1016/j.hbpd.2020.12.005
|
| 57 |
Alessandro Rizzo, Riccardo Carloni, Angela Dalia Ricci, Antonio Cusmai, Mariarita Laforgia, Concetta Calabrò, Valentina Ungaro, Donato Oreste, Mario Sollitto, Gennaro Palmiotti, Giovanni Brandi. Treatment-related adverse events of first-line immunotherapy versus sorafenib for advanced hepatocellular carcinoma: a meta-analysis. Expert Opinion on Drug Safety 2023; 22(4): 323 doi: 10.1080/14740338.2023.2152793
|
| 58 |
Jan Vosshenrich, Christoph J. Zech, Tobias Heye, Tuyana Boldanova, Geoffrey Fucile, Stefan Wieland, Markus H. Heim, Daniel T. Boll. Response prediction of hepatocellular carcinoma undergoing transcatheter arterial chemoembolization: unlocking the potential of CT texture analysis through nested decision tree models. European Radiology 2021; 31(6): 4367 doi: 10.1007/s00330-020-07511-3
|
| 59 |
Jiao Zhang, Guo‐an Feng, Yuliang Li, Wujie Wang. Drug‐eluting bead transarterial chemoembolization with medium‐sized versus small‐sized CalliSpheres microspheres in unresectable primary liver cancer. Asia-Pacific Journal of Clinical Oncology 2022; 18(4): 388 doi: 10.1111/ajco.13660
|
| 60 |
Jose Urbano, J. Javier Echevarria-Uraga, J. Jose Ciampi-Dopazo, Juan A. Sánchez-Corral, Jorge Cobos Alonso, Ane Anton-Ladislao, Borja Peña-Baranda, Veronica Nacarino-Mejias, Rocío González-Costero, J. Joaquín Muñoz Ruiz-Canela, Julian Pérez-Cuesta, Carlos Lanciego, Miguel Angel de Gregorio. Multicentre prospective study of drug-eluting bead chemoembolisation safety using tightly calibrated small microspheres in non-resectable hepatocellular carcinoma. European Journal of Radiology 2020; 126: 108966 doi: 10.1016/j.ejrad.2020.108966
|
| 61 |
Han Wang, Hua Yu, You-Wen Qian, Zhen-Ying Cao, Meng-Chao Wu, Wen-Ming Cong. Postoperative adjuvant transcatheter arterial chemoembolization improves the prognosis of patients with huge hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2021; 20(3): 232 doi: 10.1016/j.hbpd.2020.12.018
|
| 62 |
Ting Ye, Shi-Han Shao, Kan Ji, Shu-Lin Yao. Evaluation of short-term effects of drug-loaded microspheres and traditional transcatheter arterial chemoembolization in the treatment of advanced liver cancer. World Journal of Gastrointestinal Oncology 2022; 14(12): 2367-2379 doi: 10.4251/wjgo.v14.i12.2367
|
| 63 |
Ping-Wei Song, Jian-Lei Wang, Tao Wang, Hai-Ning Zou, Ye-Hui Liu. Creating and Testing a Model to Predict Postoperative Discomfort in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolisation. Hepatitis Monthly 2023; 23(1) doi: 10.5812/hepatmon-133918
|
| 64 |
Yi-Sheng Liu, Pi-Yi Chang, Po-Chin Liang, Ming-Ching Ou, Jen-I Hwang, Chien-Hung Chen. Safety and Efficacy of Drug-Eluting Beads Trans-Arterial Chemoembolization for Hepatocellular Carcinoma in Taiwan (SERENADE-T). Journal of Hepatocellular Carcinoma 2022; : 811 doi: 10.2147/JHC.S374555
|
| 65 |
Alberta Cappelli, Giuliano Peta, Rita Golfieri. Imaging of the Liver and Intra-hepatic Biliary Tract. Medical Radiology 2021; : 283 doi: 10.1007/978-3-030-39021-1_13
|
| 66 |
Haris Muhammad, Aniqa Tehreem, Peng-Sheng Ting, Merve Gurakar, Sean Young Li, Cem Simsek, Saleh A. Alqahtani, Amy K. Kim, Ruhail Kohli, Ahmet Gurakar. Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00125
|
| 67 |
Antonio Facciorusso, Rosa Paolillo, Nicola Tartaglia, Daryl Ramai, Babu P. Mohan, Christian Cotsoglou, Saurabh Chandan, Antonio Ambrosi, Irene Bargellini, Matteo Renzulli, Rodolfo Sacco. Efficacy of combined transarterial radioembolization and sorafenib in the treatment of hepatocarcinoma: A meta-analysis. Digestive and Liver Disease 2022; 54(3): 316 doi: 10.1016/j.dld.2021.06.003
|
| 68 |
Hai-Yan Wang, Xiong-Wei Cui, Yong-Hong Zhang, Yu Chen, Ning-Ning Lu, Shou-Peng Sheng, Wen-Feng Gao, Xiao-Zheng Yang, Zhong-Ping Duan. Comparison of NK cell subsets, receptors and functions induced by radiofrequency ablation and microwave ablation in HBV-associated primary hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1048049
|
| 69 |
Alice Hagan, Marcus Caine, Cara Press, Wendy M. Macfarlane, Gary Phillips, Andrew W. Lloyd, Peter Czuczman, Hugh Kilpatrick, Zainab Bascal, Yiqing Tang, Pedro Garcia, Andrew L. Lewis. Predicting pharmacokinetic behaviour of drug release from drug-eluting embolization beads using in vitro elution methods. European Journal of Pharmaceutical Sciences 2019; 136: 104943 doi: 10.1016/j.ejps.2019.05.021
|
| 70 |
WeiLu Jia, YingHui Han, XinYu Mao, WenJing Xu, YeWei Zhang. Nanotechnology strategies for hepatocellular carcinoma diagnosis and treatment. RSC Advances 2022; 12(48): 31068 doi: 10.1039/D2RA05127C
|
| 71 |
Sihang Cheng, Ge Hu, Zhengyu Jin, Zhiwei Wang, Huadan Xue. CT-based radiomics nomogram for prediction of survival after transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma and portal vein tumor thrombus. European Radiology 2023; 33(12): 8715 doi: 10.1007/s00330-023-09830-7
|
| 72 |
Seona M. Rossi, Timothy Murray, Liam McDonough, Helena Kelly. Loco-regional drug delivery in oncology: current clinical applications and future translational opportunities. Expert Opinion on Drug Delivery 2021; 18(5): 607 doi: 10.1080/17425247.2021.1856074
|
| 73 |
Yanqiao Ren, Yusheng Guo, Lei Chen, Tao Sun, Weihua Zhang, Bo Sun, Licheng Zhu, Fu Xiong, Chuansheng Zheng. Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma. Cancer Control 2022; 29: 107327482210768 doi: 10.1177/10732748221076806
|
| 74 |
Amina Tawfik, Samia Shouman, Reda Tabashy, Mervat Omran, Mohamed Gad El-Mola. Evaluation of doxorubicin administrations in hepatocellular carcinoma in terms of genetic polymorphism, case study: Egypt. Arab Gulf Journal of Scientific Research 2023; doi: 10.1108/AGJSR-04-2023-0158
|
| 75 |
Antonio Facciorusso, Mohamed A. Abd El Aziz, Nicola Tartaglia, Daryl Ramai, Babu P. Mohan, Christian Cotsoglou, Sara Pusceddu, Luca Giacomelli, Antonio Ambrosi, Rodolfo Sacco. Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials. Cancers 2020; 12(12): 3796 doi: 10.3390/cancers12123796
|
| 76 |
Qian-qian Du, Min Liang, Bo Jiang, Miao Zhang, Xiao-ling Yu, Xiao Li, Jia-hu Hao. Incidence and predictors of abdominal pain after transarterial chemoembolization of hepatocellular carcinoma: a single-center retrospective study. European Journal of Oncology Nursing 2023; 66: 102355 doi: 10.1016/j.ejon.2023.102355
|
| 77 |
Song Yi Lee, Jin Woo Choi, Jae-Young Lee, Dae-Duk Kim, Hyo-Cheol Kim, Hyun-Jong Cho. Hyaluronic acid/doxorubicin nanoassembly-releasing microspheres for the transarterial chemoembolization of a liver tumor. Drug Delivery 2018; 25(1): 1472 doi: 10.1080/10717544.2018.1480673
|
| 78 |
Katerina Malagari, Alban Denys, Marta Burrel, Maria Reig, Mercé Brunet, Rafael Duran, Theodoros Kiakidis, Hippokratis Moschouris, Marco Sanduzzi-Zamparelli, Jordi Bruix. Polyethylene Glycol Drug-Eluting Embolic Microspheres Loaded with Doxorubicin for the Treatment of Hepatocellular Carcinoma: Feasibility, Safety, and Pharmacokinetic Study. Journal of Vascular and Interventional Radiology 2022; 33(7): 752 doi: 10.1016/j.jvir.2021.11.019
|
| 79 |
Nihal Mostafa, Ahmed Salem, Somaya Z. Mansour, Sawsan M. El-Sonbaty, Fatma S. M. Moawed, Eman I. Kandil. Rationale for Tailoring an Alternative Oncology Trial Using a Novel Gallium-Based Nanocomplex: Mechanistic Insights and Preclinical Challenges. Technology in Cancer Research & Treatment 2022; 21: 153303382210853 doi: 10.1177/15330338221085376
|
| 80 |
Hua Xiang, Lin Long, Yuanhui Yao, Zhiyong Fang, Zhiming Zhang, Yongjin Zhang. CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2019; 18: 153303381983075 doi: 10.1177/1533033819830751
|
| 81 |
David S. Monahan, Talal Almas, Robert Wyile, Faisal H. Cheema, Garry P. Duffy, Aamir Hameed. Towards the use of localised delivery strategies to counteract cancer therapy–induced cardiotoxicities. Drug Delivery and Translational Research 2021; 11(5): 1924 doi: 10.1007/s13346-020-00885-3
|
| 82 |
Zhen Li, Du Xiao, Xin Li, Pengchao Zhan, Jiaxiang Wang, Henghui Zhang. Early recurrence detected in hepatocellular carcinoma patients after transcatheter arterial chemoembolization treatment with plasma cell-free DNA. European Journal of Gastroenterology & Hepatology 2019; 31(7): 885 doi: 10.1097/MEG.0000000000001373
|
| 83 |
Alexander Gross, Thomas Albrecht. Transarterial Chemoembolisation (TACE) with Degradable Starch Microspheres (DSM) and Anthracycline in Patients with Locally Extensive Hepatocellular Carcinoma (HCC): Safety and Efficacy. CardioVascular and Interventional Radiology 2020; 43(3): 402 doi: 10.1007/s00270-019-02364-w
|
| 84 |
H. Perfahl, H. V. Jain, T. Joshi, M. Horger, N. Malek, M. Bitzer, M. Reuss. Hybrid Modelling of Transarterial Chemoembolisation Therapies (TACE) for Hepatocellular Carcinoma (HCC). Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65012-1
|
| 85 |
Isabelle Mohr, Marie Vogeler, Jan Pfeiffenberger, Simon David Sprengel, Miriam Klauss, Boris Radeleff, Andreas Teufel, De-Hua Chang, Christoph Springfeld, Thomas Longerich, Uta Merle, Arianeb Mehrabi, Karl Heinz Weiss, Markus Mieth. Clinical effects and safety of different transarterial chemoembolization methods for bridging and palliative treatments in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2022; 148(11): 3163 doi: 10.1007/s00432-021-03900-3
|